drugset / Trial / NCT00553423

Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage

NCT00553423

Phase 3 Unknown 128 enrolled Aga Khan University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

To evaluate the role of lactulose in prevention of clinically overt hepatic encephalopathy (HE) in the setting of acute upper gastrointestinal bleeding in cirrhotic patients

Timeline

Start
2007-11
Primary completion
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactulose Other / unclassified 30 ml